Market Cap 61.46M
Revenue (ttm) 0.00
Net Income (ttm) -39.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -6.58
Volume 4,353,400
Avg Vol 1,824,904
Day's Range N/A - N/A
Shares Out 19.09M
Stochastic %K 2%
Beta 1.26
Analysts Strong Sell
Price Target $19.75

Company Profile

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven ca...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 209 0050
Website: elicio.com
Address:
451 D Street, 5th Floor Suite 501, Boston, United States
Harunkaraca
Harunkaraca Jul. 4 at 1:25 PM
0 · Reply
justiceforb_85
justiceforb_85 Jul. 4 at 3:33 AM
$ELTX P1 study through MSK active. Look forward to positive updates from this https://clinicaltrials.gov/study/NCT07671339?intr=ELI-002%207P&viewType=Card&rank=1
1 · Reply
MadMaverick
MadMaverick Jul. 4 at 1:31 AM
⚡WATCHLIST RECAP⚡ ✅ $DSY | +16.39% max profit ❌ $ILLR | No trade (Entry not hit) ✅ $LHAI | +6.42% max profit ✅ $ELTX | +6.74% max profit Follow to access my daily watchlist and updates. THANK YOU 👍🏼
0 · Reply
AlphaVisionn
AlphaVisionn Jul. 3 at 8:56 PM
$ELTX selling off after a $15M direct offering of 4.38M shares. Raise funds the Phase 1 ELI-002 7P trial in metastatic pancreatic cancer, plus pipeline work and working capital. Near-term pressure looks dilution-driven; execution on the trial is the key catalyst.
0 · Reply
Golferhack12
Golferhack12 Jul. 3 at 8:02 PM
$ELTX this is very confusing the company says that they're not getting any money from the sale of the shares that they are shareholders that are selling to somebody else now why would that happen but then they say they're going to use the money for their trials coming up does anybody know the real story did they have to issue new shares for this I can't really find a legitimate press release that makes sense
0 · Reply
Invescent
Invescent Jul. 3 at 1:18 PM
$ELTX 🫩
1 · Reply
Harunkaraca
Harunkaraca Jul. 3 at 10:25 AM
2 · Reply
Viktor4o
Viktor4o Jul. 3 at 9:54 AM
$ELTX Thoughts for Monday?
1 · Reply
BioBuddha
BioBuddha Jul. 3 at 1:29 AM
$ELTX i was so wrong
0 · Reply
BioBuddha
BioBuddha Jul. 3 at 1:27 AM
$ELTX incurred heavy losses. Well you die another day. Stay alive and win tomorrow
0 · Reply
Latest News on ELTX
Elicio Therapeutics joins Russell 2000, Russell 3000 Indexes

2026-06-29T12:10:43.000Z - 5 days ago

Elicio Therapeutics joins Russell 2000, Russell 3000 Indexes


Elicio Therapeutics Transcript: KOL event

Jun 24, 2026, 1:00 PM EDT - 10 days ago

Elicio Therapeutics Transcript: KOL event


Elicio Therapeutics Slides: KOL event

Jun 24, 2026, 1:00 PM EDT - 10 days ago

Elicio Therapeutics Slides: KOL event


Elicio Therapeutics Slides: Corporate presentation

Jun 24, 2026, 7:00 AM EDT - 10 days ago

Elicio Therapeutics Slides: Corporate presentation


Elicio Therapeutics assumed with a Buy at Ladenburg

2026-06-18T13:15:22.000Z - 16 days ago

Elicio Therapeutics assumed with a Buy at Ladenburg


Elicio Therapeutics Transcript: Study update

Jun 15, 2026, 8:30 AM EDT - 19 days ago

Elicio Therapeutics Transcript: Study update


Elicio Therapeutics Slides: Study update

Jun 15, 2026, 8:30 AM EDT - 19 days ago

Elicio Therapeutics Slides: Study update


Elicio Therapeutics Press release: Study update

Jun 15, 2026, 8:30 AM EDT - 19 days ago

Elicio Therapeutics Press release: Study update


Elicio Therapeutics initiated with a Buy at B. Riley

2026-06-10T12:27:56.000Z - 24 days ago

Elicio Therapeutics initiated with a Buy at B. Riley


Elicio Therapeutics Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 7 weeks ago

Elicio Therapeutics Earnings release: Q1 2026


Elicio Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 7 weeks ago

Elicio Therapeutics Quarterly report: Q1 2026


Elicio Therapeutics Reports Inducement Grants

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Elicio Therapeutics Reports Inducement Grants


Elicio Therapeutics initiated with a Buy at Ladenburg

2026-04-15T11:02:32.000Z - 2 months ago

Elicio Therapeutics initiated with a Buy at Ladenburg


Elicio Therapeutics Registration statement: Registration Filing

Mar 12, 2026, 8:00 AM EDT - 4 months ago

Elicio Therapeutics Registration statement: Registration Filing


Elicio Therapeutics Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Elicio Therapeutics Earnings release: Q4 2025


Elicio Therapeutics Annual report: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Elicio Therapeutics Annual report: Q4 2025


Elicio Therapeutics Registration statement: Registration Filing

Mar 2, 2026, 7:00 AM EST - 4 months ago

Elicio Therapeutics Registration statement: Registration Filing


Elicio Therapeutics Registration statement: Registration Filing

Feb 27, 2026, 7:00 AM EST - 4 months ago

Elicio Therapeutics Registration statement: Registration Filing


Elicio Therapeutics Slides: Corporate presentation

Jan 11, 2026, 1:30 PM EST - 6 months ago

Elicio Therapeutics Slides: Corporate presentation


Elicio Therapeutics Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Elicio Therapeutics Earnings release: Q3 2025


Elicio Therapeutics Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Elicio Therapeutics Quarterly report: Q3 2025


Elicio Therapeutics Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 8 months ago

Elicio Therapeutics Registration statement: Registration Filing


Elicio Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Elicio Therapeutics Earnings release: Q2 2025


Elicio Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Elicio Therapeutics Quarterly report: Q2 2025


Elicio Therapeutics Transcript: Status Update

Jun 25, 2025, 2:00 PM EDT - 1 year ago

Elicio Therapeutics Transcript: Status Update


Elicio Therapeutics Press release: Status Update

Jun 25, 2025, 2:00 PM EDT - 1 year ago

Elicio Therapeutics Press release: Status Update


Elicio Therapeutics Secures $10 Million in Financing

Jun 4, 2025, 8:00 AM EDT - 1 year ago

Elicio Therapeutics Secures $10 Million in Financing


Elicio Therapeutics Earnings release: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Elicio Therapeutics Earnings release: Q1 2025


Elicio Therapeutics Quarterly report: Q1 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Elicio Therapeutics Quarterly report: Q1 2025


Elicio Therapeutics Proxy statement: Proxy Filing

Apr 9, 2025, 8:00 AM EDT - 1 year ago

Elicio Therapeutics Proxy statement: Proxy Filing


Elicio Therapeutics Earnings release: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Elicio Therapeutics Earnings release: Q4 2024


Elicio Therapeutics Annual report: Q4 2024

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Elicio Therapeutics Annual report: Q4 2024


Elicio Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 6:00 PM EST - 1 year ago

Elicio Therapeutics Quarterly report: Q3 2024


Elicio Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 6:00 PM EST - 1 year ago

Elicio Therapeutics Earnings release: Q3 2024


Elicio Therapeutics Proxy statement: Proxy Filing

Sep 27, 2024, 8:00 AM EDT - 1 year ago

Elicio Therapeutics Proxy statement: Proxy Filing


Elicio Therapeutics Proxy statement: Proxy Filing

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Elicio Therapeutics Proxy statement: Proxy Filing


Elicio Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 6:00 PM EDT - 2 years ago

Elicio Therapeutics Quarterly report: Q2 2024


Elicio Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 6:00 PM EDT - 2 years ago

Elicio Therapeutics Earnings release: Q2 2024


Elicio Therapeutics Announces Proposed Public Offering

Jun 27, 2024, 4:05 PM EDT - 2 years ago

Elicio Therapeutics Announces Proposed Public Offering


Elicio Therapeutics Quarterly report: Q1 2024

May 14, 2024, 6:00 PM EDT - 2 years ago

Elicio Therapeutics Quarterly report: Q1 2024


Elicio Therapeutics Earnings release: Q1 2024

May 14, 2024, 6:00 PM EDT - 2 years ago

Elicio Therapeutics Earnings release: Q1 2024


Elicio Therapeutics Registration statement: Registration Filing

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Elicio Therapeutics Registration statement: Registration Filing


Elicio Therapeutics Annual report: Q4 2023

Mar 28, 2024, 7:00 PM EDT - 2 years ago

Elicio Therapeutics Annual report: Q4 2023


Elicio Therapeutics Earnings release: Q4 2023

Mar 28, 2024, 7:00 PM EDT - 2 years ago

Elicio Therapeutics Earnings release: Q4 2023


Harunkaraca
Harunkaraca Jul. 4 at 1:25 PM
0 · Reply
justiceforb_85
justiceforb_85 Jul. 4 at 3:33 AM
$ELTX P1 study through MSK active. Look forward to positive updates from this https://clinicaltrials.gov/study/NCT07671339?intr=ELI-002%207P&viewType=Card&rank=1
1 · Reply
MadMaverick
MadMaverick Jul. 4 at 1:31 AM
⚡WATCHLIST RECAP⚡ ✅ $DSY | +16.39% max profit ❌ $ILLR | No trade (Entry not hit) ✅ $LHAI | +6.42% max profit ✅ $ELTX | +6.74% max profit Follow to access my daily watchlist and updates. THANK YOU 👍🏼
0 · Reply
AlphaVisionn
AlphaVisionn Jul. 3 at 8:56 PM
$ELTX selling off after a $15M direct offering of 4.38M shares. Raise funds the Phase 1 ELI-002 7P trial in metastatic pancreatic cancer, plus pipeline work and working capital. Near-term pressure looks dilution-driven; execution on the trial is the key catalyst.
0 · Reply
Golferhack12
Golferhack12 Jul. 3 at 8:02 PM
$ELTX this is very confusing the company says that they're not getting any money from the sale of the shares that they are shareholders that are selling to somebody else now why would that happen but then they say they're going to use the money for their trials coming up does anybody know the real story did they have to issue new shares for this I can't really find a legitimate press release that makes sense
0 · Reply
Invescent
Invescent Jul. 3 at 1:18 PM
$ELTX 🫩
1 · Reply
Harunkaraca
Harunkaraca Jul. 3 at 10:25 AM
2 · Reply
Viktor4o
Viktor4o Jul. 3 at 9:54 AM
$ELTX Thoughts for Monday?
1 · Reply
BioBuddha
BioBuddha Jul. 3 at 1:29 AM
$ELTX i was so wrong
0 · Reply
BioBuddha
BioBuddha Jul. 3 at 1:27 AM
$ELTX incurred heavy losses. Well you die another day. Stay alive and win tomorrow
0 · Reply
justiceforb_85
justiceforb_85 Jul. 2 at 11:05 PM
$ELTX offering not ideal but will hopefully buy (literally) the company more time to see if there are additional CRs and to clarify P3 study design.
0 · Reply
Viktor4o
Viktor4o Jul. 2 at 9:35 PM
$ELTX Price prediction for tomorrow?
1 · Reply
TwoButtholes35
TwoButtholes35 Jul. 2 at 9:26 PM
$ELTX Those July 17 calls are just fucked now lol
1 · Reply
Harunkaraca
Harunkaraca Jul. 2 at 9:17 PM
$ELTX waiting till 6,50
0 · Reply
liloleme4
liloleme4 Jul. 2 at 7:53 PM
$ELTX Down 37%? Opted to double my position to 200 shares - will still keep a watch on it overall... might have to start delving deeper to see if I want a decent share, but not today. SLS is still my baby for now. When it pays off, I'll need more companies to invest in
0 · Reply
Woooehoo
Woooehoo Jul. 2 at 7:29 PM
$ELTX and this is why I bought puts last week. no brainer this was gonna drop
1 · Reply
saad545
saad545 Jul. 2 at 7:17 PM
$ELTX wrong stupid short info, I think you will be in trouble if you don’t cover at these prices🚀
0 · Reply
Golferhack12
Golferhack12 Jul. 2 at 6:59 PM
$ELTX this is what happens when you sell 15 million shares at three bucks you lower the premium and nobody's going to pay more it's going to take a while
0 · Reply
Viktor4o
Viktor4o Jul. 2 at 6:20 PM
$ELTX Where is the bottom?
0 · Reply
saad545
saad545 Jul. 2 at 3:43 PM
$ELTX It’s a registered direct offering of common stock — a straightforward sale of ~4.38 million shares at a fixed price (~$3.43 per share). No convertibles, no floating rates, and no variable share issuance tied to future price drops. Pre-offering, shares outstanding were ~19.1 million. Adding ~4.38M brings it to roughly 23.5 million post-closing (expected ~July 6). The buyers are two new fundamental institutional investors (new to the company’s shareholder base).⬆️
0 · Reply
humdime
humdime Jul. 2 at 3:24 PM
$ELTX The Phase 1 study will start in Q4 2026. From there, we could have efficacy data within just a few months.
1 · Reply
Harunkaraca
Harunkaraca Jul. 2 at 3:19 PM
$ELTX buying as mich i can! This will soar at some Point
0 · Reply